Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 2116
interventional 1828
Observational 282
Registry 6

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 678
Drug|placebo 424
Behavioral 304
Other 115
Device 100
Behavioral|Other 38
Behavioral|Drug 25
Procedure 19
Drug|Other 17
Dietary Supplement|placebo 14
Behavioral|Device 10
Dietary Supplement 10
Behavioral|Drug|placebo 9
Device|placebo 9
Drug|Other|placebo 5
Drug|Procedure 5
Combination Product 4
Device|Drug 4
Other|placebo 4
Biological 3
Genetic|Other 3
Behavioral|Drug|Other 2
Behavioral|Procedure 2
Device|Other 2
Diagnostic Test 2
Genetic 2
Other|Procedure 2
placebo 2
Behavioral|Biological|Diagnostic Test 1
Behavioral|Device|Drug 1
Behavioral|Device|placebo 1
Behavioral|Diagnostic Test|Other 1
Behavioral|Drug|Other|placebo 1
Behavioral|Drug|placebo|Radiation 1
Behavioral|Drug|Procedure 1
Behavioral|Other|Procedure 1
Combination Product|Drug 1
Dietary Supplement|Drug 1
Drug|placebo|Procedure 1
Drug|Radiation 1
NA 1
placebo|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 757
NA 203
France 72
Canada 64
China 64
Germany 59
Taiwan 44
Spain 35
United Kingdom 35
Denmark 30
Korea, Republic of 27
Israel 25
Japan 25
Brazil 17
India 15
Hong Kong 14
Australia 13
Norway 12
Switzerland 8
Italy 7
Pakistan 6
Turkey 6
United States|Puerto Rico 6
Egypt 5
Finland 5
Netherlands 5
United States|Canada 5
Austria 4
Belgium 4
Ethiopia 4
Japan|Korea, Republic of|Taiwan 4
Sweden 4
United States|India 4
Croatia 3
South Africa 3
Germany|Switzerland 2
Iran, Islamic Republic of 2
Ireland 2
Israel|Romania 2
Japan|Korea, Republic of|Malaysia|Taiwan 2
Jordan 2
Malaysia 2
Mexico 2
Moldova, Republic of 2
Poland 2
Portugal 2
Tanzania 2
Thailand 2
United States|Argentina|Australia|Colombia|Finland|France|Hungary|India|Korea, Republic of|Mexico|Romania|Russian Federation|Sweden|United Kingdom 2
United States|Bulgaria 2
United States|Bulgaria|Korea, Republic of|Malaysia|Philippines|Romania|Russian Federation|Ukraine 2
United States|Bulgaria|Latvia|Russian Federation|Serbia|Ukraine 2
United States|Bulgaria|Serbia|Ukraine 2
United States|Colombia|India|Romania|Russian Federation|Ukraine 2
United States|Croatia|Latvia 2
United States|Croatia|Russian Federation 2
United States|France|Italy|Russian Federation|Serbia|Slovakia|South Africa 2
United States|Hungary|Romania|Russian Federation|Ukraine 2
United States|India|Romania|Russian Federation|Ukraine 2
United States|Israel 2
United States|Ukraine 2
Argentina 1
Argentina|Austria|Croatia|Germany|Mexico|Portugal|Romania|Russian Federation|South Africa 1
Argentina|Brazil|Germany|Mexico|Philippines|Taiwan 1
Argentina|Colombia 1
Argentina|Croatia|India|Russian Federation|Serbia|Ukraine 1
Argentina|Egypt|Estonia|France|Greece|Jordan|Latvia|Lebanon|Lithuania|Romania|Slovakia|South Africa|Spain|Turkey 1
Argentina|Hong Kong|Italy|Poland|Russian Federation|Ukraine 1
Australia|Austria|Belgium|Bulgaria|Czechia|Denmark|France|Germany|Israel|Italy|Netherlands|Poland|Romania|Spain|Switzerland|United Kingdom 1
Australia|Austria|Norway 1
Australia|Belgium|Brazil|Croatia|Czech Republic|Mexico|Slovakia|Spain 1
Australia|Canada|Hong Kong|Korea, Republic of 1
Australia|China|Hong Kong|Korea, Republic of|Malaysia|New Zealand|Philippines|Taiwan|Thailand 1
Australia|United States|Argentina|Brazil|Bulgaria|Czechia|France|Hong Kong|Hungary|India|Italy|Korea, Republic of|Malaysia|Mexico|Poland|Russian Federation|South Africa|Spain|Taiwan|Turkey|Ukraine 1
Austria|Belgium|Bulgaria|Croatia|Czech Republic|Egypt|Estonia|France|Germany|Greece|Hungary|Israel|Jordan|Korea, Republic of|Lithuania|Poland|Romania|Russian Federation|Slovakia|South Africa|Spain|Taiwan|Turkey|Ukraine|United Kingdom 1
Austria|Belgium|Bulgaria|Czechia|Denmark|Germany|Greece|Hungary|Israel|Italy|Netherlands|Norway|Poland|Romania|Spain|United Kingdom 1
Austria|Belgium|Bulgaria|Germany|Romania|Spain 1
Austria|Belgium|Czech Republic|France|Germany|Greece|Hungary|Italy|Spain|United Kingdom 1
Austria|Czech Republic|Denmark|Finland|France|Germany|Spain|Sweden|United Kingdom 1
Austria|Czech Republic|Finland|France|Germany|Hungary|Poland|South Africa|Sweden|Switzerland|Turkey|United Kingdom 1
Austria|Denmark|Germany|Italy|Spain 1
Austria|Norway 1
Belgium|France|Germany|Hong Kong|Italy|Poland|Taiwan|Thailand 1
Belgium|France|Netherlands|Portugal|Spain 1
Belgium|Germany|Russian Federation|Slovakia|Sweden 1
Belgium|Netherlands 1
Brazil|Belgium|Bulgaria|Costa Rica|Finland|Germany|Italy|Mexico|Portugal|Romania|Russian Federation|Spain|Switzerland|Turkey 1
Brazil|Chile 1
Brazil|Colombia|Mexico 1
Brazil|Romania|Turkey 1
Bulgaria 1
Bulgaria|Czech Republic|Germany|Hungary|Norway|Romania|Slovakia|South Africa|United Kingdom 1
Bulgaria|Estonia|Germany|Hungary|Latvia|Poland|Ukraine 1
Bulgaria|Estonia|Germany|Hungary|Latvia|Ukraine 1
Bulgaria|Greece|India|Indonesia|Philippines|Romania|Russian Federation|South Africa 1
Bulgaria|Poland 1
Bulgaria|United States|Austria|Belgium|Chile|Croatia|Estonia|France|Hungary|Italy|Korea, Republic of|Poland|Puerto Rico|South Africa|Thailand 1
Canada|Colombia|Czech Republic|France|India|Lithuania|Romania|Russian Federation|Serbia|Slovakia|South Africa|Ukraine 1
Canada|Croatia|Czech Republic|France|Hungary|Netherlands|Poland|Romania|Russian Federation|South Africa|United Kingdom 1
Canada|Finland|Germany|Hungary 1
Canada|Russian Federation 1
Canada|United Kingdom 1
Chile 1
China|Hong Kong 1
China|Hong Kong|Taiwan 1
China|Japan|Korea, Republic of|Malaysia|Philippines|Russian Federation|Taiwan|Ukraine 1
China|Korea, Republic of|Malaysia|Taiwan 1
Croatia|United States|Argentina|Brazil|Chile|Israel|South Africa|Thailand 1
Czech Republic 1
Czech Republic|Estonia|Finland|France|Poland 1
Czech Republic|France|Hong Kong|Indonesia|Philippines|Poland|Spain|Thailand 1
Czech Republic|Germany|Poland|Slovakia|United Kingdom 1
Czechia|Germany 1
Denmark|Finland|Iceland|Switzerland 1
Denmark|Germany 1
Egypt|Greece|Jordan|Kuwait|Lebanon|Saudi Arabia|South Africa|Turkey|United Arab Emirates 1
Finland|Turkey 1
France|Hungary|Latvia|Romania|Russian Federation 1
France|Monaco 1
France|Switzerland 1
France|Tunisia 1
France|United States|Canada|Japan|Korea, Republic of|Spain|Taiwan 1
Germany|Spain|Brazil|Bulgaria|United States|Argentina|Belgium 1
Germany|United Kingdom 1
Ghana 1
Greece 1
Hungary 1
Hungary|Israel|Spain 1
Hungary|Japan|Korea, Republic of|United States|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|China|Czech Republic|France|Germany|Greece|Mexico|Poland|Portugal|Romania|Russian Federation|Slovakia|Spain|Sweden|Taiwan|Ukraine 1
India|Korea, Republic of|United States|Bulgaria|Croatia|Philippines|Romania|Russian Federation|Serbia|Slovakia|Taiwan|Ukraine 1
India|United States|Malaysia|Philippines|Romania|Russian Federation|Taiwan 1
India|United States|Malaysia|Russian Federation|Ukraine 1
Ireland|Israel|Latvia|Lithuania|Poland|Portugal|Romania|Austria|Bulgaria|Croatia|Czech Republic|Denmark|Estonia|France|Germany|Greece|Hungary|Saudi Arabia|Slovakia|Slovenia|Spain|Sweden|Turkey|United Kingdom 1
Ireland|United Kingdom 1
Israel|Lithuania|Poland|Romania|Germany|Croatia|France 1
Italy| 1
Latvia|United States|Canada|Japan|Korea, Republic of|Poland|Romania|Serbia|Ukraine 1
Macedonia, The Former Yugoslav Republic of 1
Montenegro 1
Netherlands|France|Belgium|Bulgaria|Croatia|Denmark|Finland|Germany|Greece|Hungary|Israel|Latvia|Lithuania|Poland|Portugal|Russian Federation|Serbia|Spain|Sweden|Switzerland|Turkey|United Kingdom 1
Poland|Romania|United Kingdom 1
Puerto Rico 1
Romania|United States|Bulgaria|Korea, Republic of|Malaysia|Philippines|Russian Federation|Ukraine 1
Russian Federation 1
Rwanda 1
Serbia 1
Singapore 1
Slovakia|United States|India|Romania|Ukraine 1
Switzerland|United Kingdom|Denmark|Finland|France|Greece|Israel|Norway|Slovenia|Sweden 1
Tunisia 1
Uganda 1
Ukraine|Austria|Belgium|Croatia|Denmark|Estonia|France|Germany|Greece|Hungary|Israel|Latvia|Lithuania|Netherlands|Portugal|Spain|Sweden|Switzerland|Turkey|United Kingdom 1
Ukraine|Bulgaria|Estonia|Korea, Republic of|Lithuania|Malaysia|Romania|Russian Federation|South Africa|Taiwan 1
Ukraine|United States|Brazil|Canada|Chile|Germany|Latvia|Lithuania|Netherlands|Poland|Slovakia|Spain|Taiwan|Turkey 1
Ukraine|United States|Bulgaria|Canada|Czechia|Hungary|Lithuania|Poland|Russian Federation|Serbia 1
Ukraine|United States|Bulgaria|Canada|Czechia|Hungary|Poland|Russian Federation|Serbia|Spain 1
Ukraine|United States|Germany|India|Malaysia|Philippines|Poland|Russian Federation|Serbia|South Africa 1
Ukraine|United States|Russian Federation|Serbia 1
United Kingdom|Turkey|Croatia|Denmark|France|Germany|Greece|Israel|Korea, Republic of|Malaysia|Netherlands|Russian Federation|Saudi Arabia|Spain|Taiwan 1
United Kingdom|United States|Argentina|Australia|Brazil|Colombia|Italy|Mexico|Poland|Romania|Russian Federation|Ukraine 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Croatia|Czech Republic|France|Germany|Hungary|Israel|Italy|Mexico|Netherlands|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Slovakia|South Africa|Spain|Sweden|Taiwan 1
United States|Argentina|Australia|Austria|Belgium|Bulgaria|Chile|Croatia|Estonia|Finland|France|Hungary|India|Korea, Republic of|Malaysia|Mexico|Norway|Philippines|Poland|Puerto Rico|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Taiwan|Thailand 1
United States|Argentina|Australia|Belgium|Canada|Colombia|Germany|Italy|Mexico|Poland|Romania|Russian Federation|Singapore|Spain|Ukraine|United Kingdom 1
United States|Argentina|Australia|Brazil|Canada|Germany|Mexico|Poland|Russian Federation|Serbia|Singapore|Spain|Ukraine 1
United States|Argentina|Australia|Bulgaria|Chile|Croatia|Estonia|Finland|Hungary|India|Korea, Republic of|Malaysia|Mexico|Philippines|Poland|Puerto Rico|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Taiwan|Thailand 1
United States|Argentina|Austria|Brazil|Germany|Ireland|Mexico|Peru|Puerto Rico|Spain|United Kingdom|Venezuela 1
United States|Argentina|Brazil|Canada|France|Greece|Portugal|Puerto Rico|Romania|Slovakia|Spain|Taiwan 1
United States|Argentina|Bulgaria|India|Malaysia|Mexico|Philippines|Romania|Russian Federation|Serbia|Slovakia|Taiwan 1
United States|Argentina|Canada|Czech Republic|Estonia|France|Hungary|Latvia|Lithuania 1
United States|Argentina|Colombia|Czech Republic|Slovakia|Ukraine 1
United States|Argentina|Russian Federation 1
United States|Australia|Bulgaria|Canada|Estonia|Finland|Germany|Hungary|Italy|Latvia|Lithuania|Spain 1
United States|Australia|Canada|France|New Zealand|United Kingdom 1
United States|Austria|Brazil|France|Germany|Hungary|Japan|Mexico|Poland|Russian Federation 1
United States|Austria|Bulgaria|Czech Republic|Estonia|France|Germany|Hungary|India|Lithuania|Poland|Russian Federation|Spain|Ukraine 1
United States|Austria|Bulgaria|Ireland|Israel|Italy|Poland|Puerto Rico|Serbia|Ukraine|United Kingdom 1
United States|Austria|Canada|Germany|Italy|Japan|Korea, Republic of|Poland|Spain|Taiwan|United Kingdom 1
United States|Austria|Germany|Ireland|Israel|Italy|Poland|Spain|Ukraine|United Kingdom 1
United States|Belgium|Bulgaria|Colombia|France|Hungary|Korea, Republic of|Malaysia|Mexico|Philippines|Poland|Puerto Rico|Romania|Russian Federation|Spain|Ukraine|United Kingdom 1
United States|Belgium|Bulgaria|Croatia|Israel|Korea, Republic of|Malaysia|Slovakia|South Africa|Spain|Taiwan 1
United States|Belgium|Bulgaria|Estonia|Finland|India|Korea, Republic of|Poland|Romania|Russian Federation|Ukraine 1
United States|Belgium|Costa Rica|Czech Republic|India|Peru|Russian Federation 1
United States|Belgium|Croatia|Korea, Republic of|Malaysia|Poland|Slovakia|Spain|Taiwan|Thailand 1
United States|Belgium|Germany|Greece|Netherlands|Poland 1
United States|Brazil 1
United States|Brazil|Canada|Chile|Germany|Latvia|Lithuania|Netherlands|Poland|Slovakia|Spain|Taiwan|Turkey|Ukraine 1
United States|Brazil|Germany|Greece|Spain|Turkey 1
United States|Brazil|Israel|Korea, Republic of|Mexico|Puerto Rico|Russian Federation 1
United States|Brazil|Mexico 1
United States|Brazil|United Kingdom 1
United States|Bulgaria|Canada|Czechia|Estonia|Finland|Mexico|Poland|Romania|Russian Federation|Serbia|Slovakia|Spain|Ukraine 1
United States|Bulgaria|Canada|Czechia|Estonia|Mexico|Poland|Romania|Russian Federation|Serbia|Slovakia|Spain|Ukraine 1
United States|Bulgaria|Canada|Czechia|Hungary|Lithuania|Poland|Russian Federation|Serbia|Spain|Ukraine 1
United States|Bulgaria|China|Czech Republic|Italy|Japan|Russian Federation 1
United States|Bulgaria|Colombia|France|Hungary|Korea, Republic of|Malaysia|Mexico|Philippines|Poland|Puerto Rico|Romania|Russian Federation|Spain|Ukraine 1
United States|Bulgaria|Croatia|India|Korea, Republic of|Philippines|Romania|Russian Federation|Serbia|Slovakia|Taiwan|Ukraine 1
United States|Bulgaria|Czech Republic 1
United States|Bulgaria|Czechia|Germany|Italy|Poland|Spain|Ukraine 1
United States|Bulgaria|Korea, Republic of|Malaysia|Poland|Puerto Rico|Romania|Russian Federation|Serbia|Taiwan|Thailand|Ukraine 1
United States|Bulgaria|Poland 1
United States|Bulgaria|Poland|Ukraine 1
United States|Bulgaria|Russian Federation|Serbia|Ukraine 1
United States|Canada|Colombia|Croatia|Japan|Korea, Republic of|Latvia|Malaysia|Mexico|Philippines|Poland|Puerto Rico|Romania|Russian Federation|Serbia|Slovakia|Taiwan|Turkey|Ukraine 1
United States|Canada|Germany|Japan|Taiwan 1
United States|Canada|Mexico|Netherlands|Puerto Rico 1
United States|Canada|United Kingdom 1
United States|China 1
United States|China|Israel 1
United States|Colombia|Croatia|Mexico|Philippines|Russian Federation|Slovakia|Taiwan 1
United States|Colombia|India|Lithuania|Philippines 1
United States|Colombia|India|South Africa 1
United States|Colombia|Korea, Republic of|Malaysia|Mexico|Romania|Turkey|Ukraine 1
United States|Colombia|Malaysia|Puerto Rico|Romania|Serbia|Turkey|Ukraine 1
United States|Colombia|Romania|Russian Federation|Slovakia|Ukraine 1
United States|Costa Rica|Korea, Republic of|Mexico|Romania|Russian Federation|South Africa|Taiwan|Ukraine 1
United States|Estonia|Poland|Romania|Russian Federation|Serbia|Slovakia|Ukraine 1
United States|France|India|Malaysia|Romania|Russian Federation|Ukraine 1
United States|Germany|Mexico|Russian Federation 1
United States|Germany|Ukraine 1
United States|Greece 1
United States|Hungary|Romania|Russian Federation|Serbia|Ukraine 1
United States|India|Malaysia|Moldova, Republic of|Philippines 1
United States|India|Malaysia|Philippines|Poland|Russian Federation|Serbia|South Africa|Ukraine 1
United States|India|Malaysia|Russian Federation|Ukraine 1
United States|India|Romania 1
United States|India|Romania|Russian Federation|Slovakia|Spain|Ukraine 1
United States|India|Russian Federation|Ukraine 1
United States|India|Taiwan 1
United States|India|Ukraine 1
United States|Israel|Italy|Spain 1
United States|Japan 1
United States|Japan|Bulgaria|China|Czech Republic|Italy|Russian Federation 1
United States|Korea, Republic of|Malaysia|Romania|Russian Federation|Serbia|Taiwan|Ukraine 1
United States|Mexico 1
United States|Poland|Puerto Rico|Russian Federation 1
United States|Puerto Rico|Russian Federation 1
United States|Romania|Russian Federation|Slovakia|Ukraine 1
United States|Romania|Russian Federation|Ukraine 1
United States|Russian Federation 1
United States|Russian Federation|Ukraine 1
United States|Russian Federation|United Kingdom 1
United States|Taiwan 1
Vietnam 1

Sites per Study

Site_count Study_Count
1 1199
2 152
3 47
4 41
5 25
6 22
7 13
8 24
9 11
10 7
11 8
12 10
13 7
14 6
15 11
16 10
17 7
18 3
19 2
20 10
21 8
22 7
23 4
24 5
25 4
26 6
27 7
28 4
29 5
30 2
31 7
32 4
33 6
34 5
35 4
36 1
37 4
38 2
39 4
41 3
42 4
43 6
44 1
45 3
46 5
48 6
49 4
50 1
51 1
52 2
53 1
54 4
55 1
56 3
57 4
58 1
59 1
60 3
61 3
62 1
63 1
64 3
65 5
66 2
67 1
69 2
71 2
72 2
73 4
74 2
75 1
76 1
80 1
81 1
82 1
83 1
84 1
86 1
87 2
88 1
90 2
92 1
94 1
98 2
99 1
101 1
102 1
103 1
106 1
107 1
110 1
113 1
116 1
117 1
120 1
122 3
124 1
129 2
138 1
141 1
147 1
148 1
157 1
177 1
214 1
236 1

Phase

Phase Study_Count
N/A 670
Phase 4 334
Phase 3 296
Phase 2 234
Phase 1 208
Phase 2/Phase 3 42
Phase 1/Phase 2 30
Early Phase 1 14

Number of Arms

Number_of_Arms Count_of_Studies
1 268
2 894
3 242
4 107
5 21
6 11
7 5
8 7
9 2
10 1
12 2
NA 268

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 2.0000 1.0000 4.00000 10.00000 5.0000 0.0000 1.0000 10.0000
1st Qu. 33.5000 38.0000 24.00000 31.00000 40.0000 45.0000 120.0000 39.5000
Median 55.0000 68.5000 40.00000 49.00000 87.0000 72.0000 300.0000 79.5000
Mean 260.0714 132.5919 54.40887 59.24138 141.6043 126.3171 386.7201 202.9024
3rd Qu. 73.7500 120.0000 65.00000 75.00000 219.7500 161.0000 493.0000 198.0000
Max. 2700.0000 10347.0000 328.00000 160.00000 880.0000 512.0000 9809.0000 18239.0000

Trial Group Type

group_type Group_Count
Experimental 1813
Active Comparator 792
Placebo Comparator 533
NA 268
Other 152
No Intervention 128
Sham Comparator 106

Intervention Model

intervention_model Study_Count
Parallel Assignment 1259
Single Group Assignment 351
Crossover Assignment 167
Factorial Assignment 28
NA 16
Sequential Assignment 7

Primary Purpose

primary_purpose Study_Count
Treatment 1434
Basic Science 94
Other 68
NA 60
Prevention 47
Health Services Research 46
Supportive Care 45
Diagnostic 29
Screening 4
Device Feasibility 1

Observational Studies

Studies by Country

Country Study_Count
United States 87
NA 38
France 17
Spain 15
Korea, Republic of 14
China 10
Canada 9
Taiwan 7
Israel 6
Norway 6
Denmark 5
Italy 5
Netherlands 5
Belgium 4
Greece 4
Croatia 3
Germany 3
Hong Kong 3
Hungary 3
Russian Federation 2
Switzerland 2
Thailand 2
Turkey 2
United States|Canada 2
Australia 1
Australia|Czech Republic|France|Italy|Russian Federation|Spain|Turkey 1
Austria 1
Austria|Finland|Germany|Netherlands 1
Belgium|France|Germany|Hungary|Italy|Spain|United Kingdom 1
Brazil|Mexico 1
Bulgaria 1
Canada|Czech Republic|Denmark|Kazakhstan|Sweden|Thailand|Ukraine 1
Croatia|Russian Federation|Turkey 1
Czech Republic|France|Germany|Greece|Russian Federation|South Africa|Spain|Turkey 1
Egypt|Saudi Arabia|United Arab Emirates 1
France|Germany|Greece 1
France|Germany|Italy|Spain 1
Germany|Greece|Netherlands|Spain 1
Hungary|Latvia|Romania 1
India 1
Italy|Argentina|Brazil|Canada|France|Germany|Spain|United Kingdom 1
Kazakhstan|Greece|Israel|Belgium|Bulgaria|Denmark|Germany|Russian Federation 1
Latvia 1
Portugal 1
Romania 1
Singapore 1
Slovenia 1
Sweden 1
United Kingdom 1
United States|Australia 1
United States|Canada|Israel|Singapore|United Kingdom 1
United States|France|Russian Federation 1

Sites per Study

Site_count Study_Count
1 197
2 10
3 8
4 5
5 1
6 5
7 5
8 2
9 1
10 3
11 3
12 1
13 1
14 4
15 2
16 1
17 2
18 2
19 1
20 2
24 1
25 2
32 1
33 1
34 2
35 1
37 1
39 1
41 1
43 1
44 1
45 1
46 1
48 1
52 1
53 1
57 1
61 1
65 1
67 1
88 1
99 1
107 1
148 1

Enrollment Metrics

Measure Observational
Min 1.000
1st Qu 72.000
Median 193.000
Mean 6555.119
3rd Qu 595.250
Max 751725.000

Observation Model

observational_model Study_Count
Cohort 96
NA 56
Case-Only 43
Case-Control 33
Case Control 19
Other 12
Defined Population 8
Ecologic or Community 6
Family-Based 6
Defined Population, Natural History 2
Case-Crossover 1

Time Perspective

time_perspective Study_Count
Prospective 156
Cross-Sectional 50
Retrospective 31
NA 18
Other 16
Longitudinal, Retrospective/Prospective 6
Cross-Sectional, Prospective 2
Cross-Sectional, Retrospective 2
Longitudinal, Prospective 1

Registries

Studies by Country

Country Study_Count
China 3
United States 2
Spain 1

Sites per Study

Site_count Study_Count
1 6

Enrollment Metrics

Measure Registries
Min 30.000
1st Qu 144.250
Median 538.500
Mean 1217.833
3rd Qu 2075.000
Max 3600.000

Registry Model

observational_model Study_Count
Case-Control 3
Cohort 2
Case-Only 1

Time Perspective

time_perspective Study_Count
Prospective 5
Cross-Sectional 1

Follow-up

target_duration Study_Count
8 Weeks 3
15 Months 1
2 Days 1
24 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT04220099 Electroencephalogram (EEG) and Electroconvulsive Therapy(ECT) Response in Schizophrenia https://ClinicalTrials.gov/show/NCT04220099 Completed Shanghai Mental Health Center 2020-06-05
NCT03919994 Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS) https://ClinicalTrials.gov/show/NCT03919994 Recruiting Alkermes, Inc. 2022-10-31
NCT03820362 The Role of Personal Identity in Psychotic Symptoms: a Study With the Repertory Grid Technique https://ClinicalTrials.gov/show/NCT03820362 Completed University of Barcelona 2018-11-30
NCT00001486 Genetic Study of Schizophrenia https://ClinicalTrials.gov/show/NCT00001486 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT03355781 Childhood Trauma in Schizophrenia: Exploration of Links Between Gene Expression, Cerebral Morphology and Symptomatology https://ClinicalTrials.gov/show/NCT03355781 Recruiting Centre Hospitalier Universitaire de Saint Etienne 2022-01-31
NCT03253367 Phenomics and Genomics of Clozapine Pharmacotherapy https://ClinicalTrials.gov/show/NCT03253367 Recruiting UMC Utrecht 2021-12-31
NCT03235908 Copeptin in Outcome Prediction of an Acute Psychotic Episode https://ClinicalTrials.gov/show/NCT03235908 Active, not recruiting University Hospital, Basel, Switzerland 2020-07-31
NCT03166098 The Role of Dysmyelination in Cognitive Impairment of Psychotic Spectrum Disorders https://ClinicalTrials.gov/show/NCT03166098 Active, not recruiting NYU Langone Health 2020-11-30
NCT03131505 INCLUDE: Using Lived Experience to Improve Mental Health Diagnosis v1 https://ClinicalTrials.gov/show/NCT03131505 Completed Norfolk and Suffolk NHS Foundation Trust 2017-12-01
NCT03130478 Predictors of Persistence in Patients With Schizophrenia Treated With Once-monthly Aripiprazole in Spain https://ClinicalTrials.gov/show/NCT03130478 Completed Otsuka Pharmaceutical Europe Ltd 2018-07-30
NCT03130465 Aripiprazole Once-monthly Versus Daily Oral Atypical Antipsychotic Treatment in Patients With Recent-onset Schizophrenia https://ClinicalTrials.gov/show/NCT03130465 Recruiting Otsuka Pharmaceutical Europe Ltd 2020-01-31
NCT03075202 Role of an E-cigarette on Smoking Displacement in Smokers With Schizophrenia https://ClinicalTrials.gov/show/NCT03075202 Completed Weill Medical College of Cornell University 2018-12-24
NCT03068806 Brain Imaging, Attention, and Auditory Processing in Schizophrenia https://ClinicalTrials.gov/show/NCT03068806 Completed San Francisco Veterans Affairs Medical Center 2018-05-11
NCT03068793 Reward Processing in Mental Illness https://ClinicalTrials.gov/show/NCT03068793 Completed San Francisco Veterans Affairs Medical Center 2019-06-30
NCT03040505 Future Mental Projections in Schizophrenia https://ClinicalTrials.gov/show/NCT03040505 Recruiting University Hospital, Strasbourg, France 2020-04-30
NCT03005769 Demographic and Clinical Predictors of Persistence in Patients Treated With Aripiprazole Once-monthly in Italy https://ClinicalTrials.gov/show/NCT03005769 Completed Otsuka Pharmaceutical Europe Ltd 2017-07-31
NCT02930083 Validating Three Common Occupational Therapy Assessments in Participants With Schizophrenia https://ClinicalTrials.gov/show/NCT02930083 Completed Taipei City Hospital 2014-12-31
NCT02921243 Schizophrenia and the Gut Microbiome https://ClinicalTrials.gov/show/NCT02921243 Completed University of Maryland, Baltimore 2019-06-18
NCT02916303 Cost-effectiveness of Interventions in First-episode Psychosis https://ClinicalTrials.gov/show/NCT02916303 Enrolling by invitation Fundación Marques de Valdecilla 2017-07-31
NCT02897167 Study of the Activation of Proinflammatory Pathways of Toll-like Receptors in Schizophrenia Patients https://ClinicalTrials.gov/show/NCT02897167 Completed Fundación Marques de Valdecilla 2018-12-31
NCT02874560 Evaluation of the Functional Remission Occurrence and Predictive Factors in Schizophrenia https://ClinicalTrials.gov/show/NCT02874560 Completed Janssen-Cilag Ltd. 2017-06-30
NCT02874482 Cognitive and Emotional Factors in Visual Exploration Among Patients With Schizophrenia https://ClinicalTrials.gov/show/NCT02874482 Recruiting University Hospital, Lille 2020-08-31
NCT02868879 Anatomical and Structural Connectivity in Two Psychotic Phenotypes : Periodic Catatonia and Cataphasia https://ClinicalTrials.gov/show/NCT02868879 Completed University Hospital, Strasbourg, France 2019-09-30
NCT02775864 Comparative Effectiveness of Adaptive Treatment Strategies for Schizophrenia https://ClinicalTrials.gov/show/NCT02775864 Completed New York State Psychiatric Institute 2018-04-30
NCT02773108 Somatic Comorbidities in Psychiatric Patients https://ClinicalTrials.gov/show/NCT02773108 Completed Sveti Ivan Psychiatric Hospital 2016-06-30
NCT02756065 Connectomics in Psychiatric Classification of Bipolar Disorder and Schizophrenia https://ClinicalTrials.gov/show/NCT02756065 Recruiting Washington University Early Recognition Center 2019-06-30
NCT02714894 Response to Clozapine in Treatment Resistant Schizophrenia: A Longitudinal Magnetic Resonance Spectroscopy Study https://ClinicalTrials.gov/show/NCT02714894 Recruiting Centre for Addiction and Mental Health 2021-03-31
NCT02712463 A Study to Assess the Rate of Hospitalization in Participants With Schizophrenia Treated With Antipsychotics https://ClinicalTrials.gov/show/NCT02712463 Completed Janssen-Cilag Ltd. 2016-04-30
NCT02681822 Multi-center Imaging Genetics Studies in China https://ClinicalTrials.gov/show/NCT02681822 Recruiting Tianjin Medical University General Hospital 2019-12-31
NCT02640911 An Observational Study on Atypical Antipsychotics Long-term Treatment Patients With Schizophrenia https://ClinicalTrials.gov/show/NCT02640911 Recruiting Shanghai Mental Health Center 2021-05-31
NCT02600741 Family Intervention in Recent Onset Schizophrenia Treatment (FIRST) https://ClinicalTrials.gov/show/NCT02600741 Completed Janssen Scientific Affairs, LLC 2018-07-05
NCT00001247 Inpatient Evaluation of Adults With Schizophrenia https://ClinicalTrials.gov/show/NCT00001247 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT02582736 Antipsychotics and Risk of Hyperglycemic Emergencies https://ClinicalTrials.gov/show/NCT02582736 Completed Canadian Network for Observational Drug Effect Studies, CNODES 2012-12-31
NCT02575209 Gender Differences in Social Cognition in Patients With Schizophrenia of Recent Diagnosis and Healthy Controls Subjects https://ClinicalTrials.gov/show/NCT02575209 Completed Corporacion Parc Tauli 2016-07-31
NCT00942981 Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography https://ClinicalTrials.gov/show/NCT00942981 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT00024622 PET Scanning in Parkinson s Disease https://ClinicalTrials.gov/show/NCT00024622 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT00001246 Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers https://ClinicalTrials.gov/show/NCT00001246 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT02034253 Glutamate, Brain Connectivity and Duration of Untreated Psychosis https://ClinicalTrials.gov/show/NCT02034253 Completed University of Alabama at Birmingham 2018-11-30
NCT02532842 Non-Interventional Study of Participants With Newly Diagnosed Schizophrenia Treated With Paliperidone Palmitate https://ClinicalTrials.gov/show/NCT02532842 Completed Janssen Pharmaceutica N.V., Belgium 2015-09-30
NCT02505022 Role Functioning Changes NOS https://ClinicalTrials.gov/show/NCT02505022 Recruiting Northwestern University 2021-01-31
NCT02476877 A Pilot, Proof-of-concept Cohort Study of the Prevalence of Comorbid Mental Illness and Substance Abuse https://ClinicalTrials.gov/show/NCT02476877 Completed Advanced Clinical Laboratory Solutions, Inc. 2016-01-31
NCT02453763 In Vivo Imaging of Therapeutic Electric Current Flow https://ClinicalTrials.gov/show/NCT02453763 Completed University of Florida 2017-07-06
NCT02439099 Retinoic Acid Homeostasis in Neuropsychiatric Diseases https://ClinicalTrials.gov/show/NCT02439099 Recruiting Charite University, Berlin, Germany 2019-12-31
NCT03386851 Abilify Maintena PMS in Schizophrenia Patients or Bipolar 1 Disorder https://ClinicalTrials.gov/show/NCT03386851 Recruiting Korea Otsuka Pharmaceutical Co., Ltd. 2021-12-22
NCT02409823 Clinical Registry of Patients Under Treatment With Atypical Antipsychotics https://ClinicalTrials.gov/show/NCT02409823 Completed Pontifical Catholic University of Argentina 2015-08-31
NCT02388607 Sustained Attention Abilities in Schizophrenia https://ClinicalTrials.gov/show/NCT02388607 Recruiting University Hospital, Strasbourg, France 2021-03-31
NCT02321943 Anomalous Self-Experience in First Episode Psychosis - A Six-Year Follow-Up Study https://ClinicalTrials.gov/show/NCT02321943 Completed Sykehuset Innlandet HF 2016-12-31
NCT02281162 The Influence of Vitamin D on Atypical Antipsychotic-induced Weight Gain https://ClinicalTrials.gov/show/NCT02281162 Completed Creighton University 2015-09-30
NCT02246283 Schizophrenia for “Life” - a Registry and Interview Study Among Elderly With Lifelong Schizophrenia https://ClinicalTrials.gov/show/NCT02246283 Completed University of Southern Denmark 2015-09-30
NCT02248987 Study on Abnormal Dopamine Synthesis and Connectivity According to the Antipsychotic Treatment Response in Schizophrenia https://ClinicalTrials.gov/show/NCT02248987 Completed Seoul National University Hospital 2016-05-31
NCT02205437 Novel Candidate Genes for Treatment Response to Antipsychotics in Schizophrenia https://ClinicalTrials.gov/show/NCT02205437 Recruiting Fundación Marques de Valdecilla 2020-12-31
NCT02187835 Decreased EEG Complexity in Schizophrenia https://ClinicalTrials.gov/show/NCT02187835 Completed Uskudar University 2014-01-31
NCT02166918 Factors Influencing Social Functioning of People With Schizophrenia https://ClinicalTrials.gov/show/NCT02166918 Completed University of Campania “Luigi Vanvitelli” 2014-07-31
NCT02118571 Schizophrenia Cognition Scale Development https://ClinicalTrials.gov/show/NCT02118571 Completed HealthCore-NERI 2016-07-31
NCT01315509 Dental Status of Patients With Severe Mental Illness https://ClinicalTrials.gov/show/NCT01315509 Completed Hadassah Medical Organization 2012-09-30
NCT01309373 An Epidemiological Study to Assess the Psychosocial and Symptomatic Remission and Community Integration Status in Patients With Schizophrenia https://ClinicalTrials.gov/show/NCT01309373 Completed Janssen-Cilag, S.A. NA
NCT01298349 Perception Processing in Schizophrenia Patients and Normal Population https://ClinicalTrials.gov/show/NCT01298349 Completed HaEmek Medical Center, Israel 2016-12-31
NCT01269710 Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study https://ClinicalTrials.gov/show/NCT01269710 Completed University of North Carolina, Chapel Hill 2011-03-31
NCT02050854 Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or Schizophrenia https://ClinicalTrials.gov/show/NCT02050854 Completed Otsuka Pharmaceutical Development & Commercialization, Inc. 2014-01-31
NCT02009826 Psychosis-Associated Neuroinflammation in Schizophrenia https://ClinicalTrials.gov/show/NCT02009826 Completed Universiteit Antwerpen 2017-02-28
NCT02006862 eVAluatIon of OLanzapine TreatmEnT https://ClinicalTrials.gov/show/NCT02006862 Completed Elpen Pharmaceutical Co. Inc. 2014-12-31
NCT01998516 Emotional Intelligence in Schizophrenia and Bipolar-I- Disorder https://ClinicalTrials.gov/show/NCT01998516 Completed Medical University Innsbruck 2016-12-31
NCT01959659 A Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia to Describe Medical Resource Utilization and Burden of Illness https://ClinicalTrials.gov/show/NCT01959659 Completed Hoffmann-La Roche 2014-04-30
NCT01943175 Stem Cell Research on Subjects at Genetic High Risk for Schizophrenia https://ClinicalTrials.gov/show/NCT01943175 Completed Seoul National University Hospital 2015-11-30
NCT01926912 A Study of Usage of Paliperidone Palmitate in Patients With Schizophrenia in a Hospital Setting https://ClinicalTrials.gov/show/NCT01926912 Completed Janssen-Cilag International NV 2014-08-31
NCT01926340 Early Medication Discontinuation and Long-term Clinical Outcome in FEP https://ClinicalTrials.gov/show/NCT01926340 Completed The University of Hong Kong 2014-12-31
NCT01886417 Auditory Verbal Hallucinations in Schizophrenia https://ClinicalTrials.gov/show/NCT01886417 Completed University Hospital, Grenoble 2015-03-31
NCT01846065 Tobacco Craving and Triggers in Persons With Schizophrenia https://ClinicalTrials.gov/show/NCT01846065 Completed University of Maryland, Baltimore 2016-06-30
NCT01819818 A Study to Observe the Safety and Tolerability of Paliperidone Palmitate (Invega Sustenna) in Korean Schizophrenic Patients https://ClinicalTrials.gov/show/NCT01819818 Completed Janssen Korea, Ltd., Korea 2019-11-29
NCT01795326 Physician Survey on Monitoring of Patients Treated With Quetiapine https://ClinicalTrials.gov/show/NCT01795326 Completed AstraZeneca 2013-09-30
NCT01793324 EMR Data to Assess Monitoring of Patients Treated With Quetiapine https://ClinicalTrials.gov/show/NCT01793324 Completed AstraZeneca 2013-06-30
NCT01786369 Adherence in Patients Admitted to a Psychiatric Unit for Acute Psychosis: an Analysis of Serum Levels of Antipsychotics. https://ClinicalTrials.gov/show/NCT01786369 Completed Northwell Health 2015-04-30
NCT01754532 Correlation Between Clinical Deterioration in Schizophrenic Patients and Hair Cortisol Levels https://ClinicalTrials.gov/show/NCT01754532 Completed Shalvata Mental Health Center 2015-06-30
NCT01746134 The Management of Schizophrenia in Clinical Practice (MOSAIC) https://ClinicalTrials.gov/show/NCT01746134 Completed Genentech, Inc. 2014-05-31
NCT01730781 Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning https://ClinicalTrials.gov/show/NCT01730781 Recruiting Yale University 2020-12-31
NCT01689389 Description of the Use of Quetiapine Extended Release (XR) in Real-life Practice in France. An Observational Study https://ClinicalTrials.gov/show/NCT01689389 Completed AstraZeneca 2014-12-31
NCT01686815 Cross-Sectional Iloperidone IVGTT https://ClinicalTrials.gov/show/NCT01686815 Completed Massachusetts General Hospital 2016-05-31
NCT01660880 Validation of Receptor Occupancy Simulation https://ClinicalTrials.gov/show/NCT01660880 Completed Seoul National University Hospital 2013-12-31
NCT01634542 An Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia https://ClinicalTrials.gov/show/NCT01634542 Completed Hoffmann-La Roche 2014-12-31
NCT01629355 Auditory Brainstem Response as a Diagnostic Tool in Schizophrenia and Bipolar Disorder https://ClinicalTrials.gov/show/NCT01629355 Completed University Hospital of North Norway 2015-05-31
NCT01602263 Transcranial Direct Current Stimulation (tDCS) and Cognitive Processing https://ClinicalTrials.gov/show/NCT01602263 Active, not recruiting Johns Hopkins University 2025-01-31
NCT01590784 Reliability and Validity of Thai Calgary Depression Scale of Schizophrenia (CDSS) https://ClinicalTrials.gov/show/NCT01590784 Completed Chiang Mai University 2014-06-30
NCT01587521 Prevalence of and Factors Associated With Metabolic Syndrome in Schizophrenia https://ClinicalTrials.gov/show/NCT01587521 Completed Chiang Mai University 2016-06-30
NCT01575912 Past Pain Experience and Perception of Experimental Pain https://ClinicalTrials.gov/show/NCT01575912 Completed Centre Hospitalier Esquirol 2014-01-31
NCT01558570 Intracellular Tight Junction Permeability in Schizophrenia: Focus on Zonulin https://ClinicalTrials.gov/show/NCT01558570 Completed University of Maryland, Baltimore 2012-02-29
NCT01544608 Observe Real-life Allocation of Atypical Antipsychotics in the Acute Inpatient Management of Schizophrenia https://ClinicalTrials.gov/show/NCT01544608 Completed AstraZeneca 2012-12-31
NCT01495741 Post-Authorization Safety Surveillance Study of Asenapine in Participants With Bipolar Disorder (P08307) https://ClinicalTrials.gov/show/NCT01495741 Completed Merck Sharp & Dohme Corp. 2017-12-18
NCT01491412 Non-interventional Study: Real-life Use of Atypical Antipsychotics in Acute Inpatient Management of Schizophrenia https://ClinicalTrials.gov/show/NCT01491412 Completed AstraZeneca NA
NCT01479413 Mitochondria and Schizophrenia: Effects of Antipsychotic Drugs https://ClinicalTrials.gov/show/NCT01479413 Completed Chang Gung Memorial Hospital 2012-07-31
NCT01479400 Effects of Exposed to Antipsychotics Throughout Pregnancy on Infants Development: A Prospective Study https://ClinicalTrials.gov/show/NCT01479400 Completed Central South University 2010-12-31
NCT01447082 General Practice Research Database Seroquel XR Safety Study https://ClinicalTrials.gov/show/NCT01447082 Completed AstraZeneca 2012-12-31
NCT01431326 Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care https://ClinicalTrials.gov/show/NCT01431326 Completed Duke University 2019-11-30
NCT01425684 Brain Circuits in Schizophrenia and Smoking https://ClinicalTrials.gov/show/NCT01425684 Recruiting University of Maryland, Baltimore 2020-01-31
NCT01425671 Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease States https://ClinicalTrials.gov/show/NCT01425671 Active, not recruiting University of Maryland, Baltimore 2020-01-31
NCT01409109 Database Registry for Neural Network Biomarkers in Psychosis https://ClinicalTrials.gov/show/NCT01409109 Active, not recruiting University of Texas Southwestern Medical Center 2023-05-31
NCT01399437 Brain Functions Underlying Visuospatial Attention Deficits in Schizophrenia https://ClinicalTrials.gov/show/NCT01399437 Completed National Institutes of Health Clinical Center (CC) NA
NCT01394601 A Study to Observe Real-life Allocation of Antipsychotics in Acute Inpatient Management of Schizophrenia https://ClinicalTrials.gov/show/NCT01394601 Completed AstraZeneca 2011-12-31
NCT01392885 Brain Health and Exercise in Schizophrenia https://ClinicalTrials.gov/show/NCT01392885 Enrolling by invitation BC Mental Health and Addictions Research Institute 2016-06-30
NCT01392482 IBIS: Italian Burden of Illness on Schizophrenia & Bipolar Disorder https://ClinicalTrials.gov/show/NCT01392482 Completed AstraZeneca 2012-09-30
NCT01384604 Neurophysiological Studies in Schizophrenia and Psychiatric Disorders https://ClinicalTrials.gov/show/NCT01384604 Completed University of Texas Southwestern Medical Center 2013-05-31
NCT01383915 Clinical Risk State for Bipolar Disorder in Adolescents https://ClinicalTrials.gov/show/NCT01383915 Recruiting Northwell Health 2022-12-31
NCT01378403 Evaluation of Dorsal Visual Stream in Patients With Schizophrenia https://ClinicalTrials.gov/show/NCT01378403 Completed Sheba Medical Center 2010-07-31
NCT01377896 The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription Behaviours https://ClinicalTrials.gov/show/NCT01377896 Completed AstraZeneca 2010-10-31
NCT01376492 FYS Study: Epidemiological, Multicentre, Cross-sectional Study in a Clinical Practice Environment, About the Relationship Between Functioning Status and the Quality of Sleep Perceived by Schizophrenic Outpatients in Spain https://ClinicalTrials.gov/show/NCT01376492 Completed Janssen-Cilag, S.A. 2011-07-31
NCT01369966 Brain Circuits in Schizophrenia and Smoking https://ClinicalTrials.gov/show/NCT01369966 Completed National Institutes of Health Clinical Center (CC) NA
NCT01362426 Paliperidone Palmitate Effectiveness Assessment Registry - Longitudinal (PEARL) https://ClinicalTrials.gov/show/NCT01362426 Completed Janssen-Cilag Pty Ltd 2013-05-31
NCT01342120 PHARMO Institute Seroquel Safety Study https://ClinicalTrials.gov/show/NCT01342120 Completed AstraZeneca 2010-11-30
NCT04335916 Survey on Pre-ECT Evaluation and ECT Application https://ClinicalTrials.gov/show/NCT04335916 Recruiting Klinički Bolnički Centar Zagreb 2020-09-01
NCT04294719 A Study of Cognitive Adaptation Training in Inpatient Forensic Environments https://ClinicalTrials.gov/show/NCT04294719 Recruiting Centre for Addiction and Mental Health 2020-06-30
NCT04280367 Learning and Executive Function Disorders in Children and Psychosis Risk at Adult-age https://ClinicalTrials.gov/show/NCT04280367 Recruiting Assistance Publique - Hôpitaux de Paris 2021-02-28
NCT04230590 Health Outcomes Via Positive Engagement in Schizophrenia https://ClinicalTrials.gov/show/NCT04230590 Recruiting Institute of Mental Health, Singapore 2022-04-30
NCT04191200 Oral Status of Patients Suffering From SCHIZophrenia Followed at Charles Perrens Hospital https://ClinicalTrials.gov/show/NCT04191200 Completed Centre Hospitalier Charles Perrens, Bordeaux 2019-12-31
NCT04064476 The Effect of Long-acting Antipsychotics on Schizophrenia Patients With Violence Risk https://ClinicalTrials.gov/show/NCT04064476 Enrolling by invitation Huazhong University of Science and Technology 2021-08-15
NCT04051775 Non-Pharmacological Treatment of Psychosis https://ClinicalTrials.gov/show/NCT04051775 Recruiting Haukeland University Hospital 2022-06-30
NCT04025502 Event-Related Potential (ERP) Biomarkers in Subjects With Schizophrenia and Healthy Volunteer Subjects https://ClinicalTrials.gov/show/NCT04025502 Recruiting ERP Biomarker Qualification Consortium 2020-02-29
NCT04024371 Validating Reward-related Biomarkers (RTOC) https://ClinicalTrials.gov/show/NCT04024371 Recruiting Maastricht University 2020-08-01
NCT04002258 Prolactin Change in Chinese Patients With Schizophrenia After Antipsychotics Treatment https://ClinicalTrials.gov/show/NCT04002258 Active, not recruiting Shanghai Mental Health Center 2020-11-30
NCT03996122 Research of Anatomo-functional Biomarkers in Schizophrenia https://ClinicalTrials.gov/show/NCT03996122 Recruiting University Hospital, Caen 2021-04-04
NCT03995121 SV2 PET Imaging With [11C]APP311 https://ClinicalTrials.gov/show/NCT03995121 Active, not recruiting Yale University 2023-12-31
NCT03965598 Study on Predictiors and Mechanism of Conversion to Psychosis in Individuals at Ultra-high Risk Group https://ClinicalTrials.gov/show/NCT03965598 Recruiting Second Xiangya Hospital of Central South University 2021-12-31
NCT03919760 Early Psychosis Intervention - Spreading Evidence-based Treatment https://ClinicalTrials.gov/show/NCT03919760 Recruiting Centre for Addiction and Mental Health 2023-05-31
NCT03809325 A Survey to Collect Treatment Experience Feedback From Patients, Physicians, Nurses and Carers After Switching to Paliperidone Palmitate 3-monthly https://ClinicalTrials.gov/show/NCT03809325 Completed Janssen-Cilag International NV 2019-07-12
NCT03788811 ERG Components in Schizophrenia and Bipolar Disorder Type I https://ClinicalTrials.gov/show/NCT03788811 Recruiting diaMentis Inc. 2020-12-31
NCT03702933 D-serine in Schizophrenia https://ClinicalTrials.gov/show/NCT03702933 Recruiting Herzog Hospital 2021-09-01
NCT03699501 Psychometric Validation of an Oral Health-related Scale for Quality of Life and Coping in People With Schizophrenia https://ClinicalTrials.gov/show/NCT03699501 Recruiting Centre Hospitalier Universitaire Dijon 2020-11-30
NCT03675750 Effects of Hyperprolactinemia Induced by Antipsychotic Drugs on Bone Metabolism https://ClinicalTrials.gov/show/NCT03675750 Recruiting Shanghai Mental Health Center 2020-04-30
NCT03693794 A Study in Italy About Evidence Based Psychosocial/Rehabilitative Interventions in Patients With Early Schizophrenia Treated Continuously With Antipsychotics https://ClinicalTrials.gov/show/NCT03693794 Recruiting Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 2020-07-01
NCT03666715 A Study to Analyze the Impact of Treatment With Paliperidone Palmitate on Clinical Outcomes and Hospital Resource Utilization in Adult Participants With Schizophrenia in Portugal https://ClinicalTrials.gov/show/NCT03666715 Recruiting Janssen-Cilag Farmaceutica Ltda. 2020-10-30
NCT03629951 A Study for Schizophrenia Relapse Prediction https://ClinicalTrials.gov/show/NCT03629951 Active, not recruiting Janssen Research & Development, LLC 2021-11-14
NCT03558529 Feasibility and Acceptability of a Smartphone App to Assess Early Warning Signs of Psychosis Relapse https://ClinicalTrials.gov/show/NCT03558529 Completed Manchester Academic Health Science Centre 2018-04-01
NCT03528278 Using Motivational Techniques to Increase Levels of Physical Activity in Long Term Psychiatric Inpatient Wards https://ClinicalTrials.gov/show/NCT03528278 Completed Oslo University Hospital 2015-03-10
NCT03525054 Semantic and Syntactic Computerized Analysis of Free Speech https://ClinicalTrials.gov/show/NCT03525054 Recruiting University Hospital, Brest 2022-05-18
NCT03523741 Therapeutic Drug Monitoring for Individualized Clozapine Therapy https://ClinicalTrials.gov/show/NCT03523741 Recruiting Seoul National University Hospital 2020-11-30
NCT03513549 Observational Study Evaluating the Safety of ADASUVE® in Agitation Associated With Schizophrenia or Bipolar I Disorder https://ClinicalTrials.gov/show/NCT03513549 Recruiting Galen Limited 2019-10-31
NCT03485339 Substance Misuse To Psychosis for Ketamine (SToP-K) https://ClinicalTrials.gov/show/NCT03485339 Active, not recruiting The University of Hong Kong 2020-06-05
NCT03481465 Searching for Early Biomarkers of Long-term Hepatic, Metabolic and Endothelial Dysfunction in Non-affective Psychosis https://ClinicalTrials.gov/show/NCT03481465 Enrolling by invitation Fundación Marques de Valdecilla 2019-12-31
NCT03476473 Early Detection of Respiratory Disorders in Psychosis https://ClinicalTrials.gov/show/NCT03476473 Enrolling by invitation Fundación Marques de Valdecilla 2018-03-26
NCT03471013 Impact of Caregiver Beliefs on Adherence to Antipsychotic Medications in Patients With Schizophrenia https://ClinicalTrials.gov/show/NCT03471013 Recruiting University Hospital, Clermont-Ferrand 2019-03-02
NCT03449407 Multi-dimensional Investigations of Negative Emotions and Drug-resistant Auditory Verbal Hallucinations in Psychosis https://ClinicalTrials.gov/show/NCT03449407 Completed Chinese University of Hong Kong 2019-06-30
NCT03414151 Gut Microbiome in AP Naive https://ClinicalTrials.gov/show/NCT03414151 Recruiting Centre for Addiction and Mental Health 2022-03-31
NCT01245348 Relative Effectiveness of Schizophrenia Therapy Study https://ClinicalTrials.gov/show/NCT01245348 Completed Medco Health Solutions, Inc. 2012-12-31
NCT01243034 Waist Circumference Measurements in Schizophrenic Patients https://ClinicalTrials.gov/show/NCT01243034 Completed Changhua Christian Hospital 2011-07-31
NCT01222793 Effects of Antipsychotics on Eating and Food Craving in People With Schizophrenia https://ClinicalTrials.gov/show/NCT01222793 Completed National Institutes of Health Clinical Center (CC) NA
NCT01214135 A Retrospective Non-interventional Study to Evaluate the Use of Seroquel Extended Release (XR) and Immediate Release (IR) in the Clinical Practice of Inpatients With Schizophrenia https://ClinicalTrials.gov/show/NCT01214135 Completed AstraZeneca 2010-12-31
NCT01212575 A Retrospective NIS to Evaluate the Use of Seroquel XR and IR in the Clinical Practice of Outpatients With Schizophrenia https://ClinicalTrials.gov/show/NCT01212575 Completed AstraZeneca 2011-02-28
NCT01212081 Assessment of Cannabis Craving in Schizophrenia Using Virtual Reality https://ClinicalTrials.gov/show/NCT01212081 Completed National Institutes of Health Clinical Center (CC) NA
NCT01202617 Seroquel XR in the Long Term Treatment of Schizophrenia https://ClinicalTrials.gov/show/NCT01202617 Completed AstraZeneca 2011-10-31
NCT01196858 Duration of Untreated Psychosis (DUP) and Pathways to Care in Nordland https://ClinicalTrials.gov/show/NCT01196858 Completed University Hospital of North Norway 2013-09-30
NCT01191827 fMRI Cholinergic Mechanisms in Schizophrenia https://ClinicalTrials.gov/show/NCT01191827 Completed VA Office of Research and Development 2011-12-31
NCT01181960 Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations https://ClinicalTrials.gov/show/NCT01181960 Completed Janssen Scientific Affairs, LLC 2013-11-30
NCT01170689 The Prevalence of Obesity For Schizophrenia Inpatients in Taiwan https://ClinicalTrials.gov/show/NCT01170689 Completed TsaoTun Psychiatric Center, Department of Health, Taiwan 2010-03-31
NCT01160679 Effectiveness of Atypical Antipsychotics on Anhedonic Features in Patients With Schizophrenia https://ClinicalTrials.gov/show/NCT01160679 Completed AstraZeneca 2011-08-31
NCT01150734 Neuromodulation in Depressed and Schizophrenic Patients - Changing MEP (Muscle Evoked Potentials) by tDCS (Transcranial Direct Current Stimulation) https://ClinicalTrials.gov/show/NCT01150734 Completed Ludwig-Maximilians - University of Munich 2010-12-31
NCT01149551 CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness https://ClinicalTrials.gov/show/NCT01149551 Completed VA Office of Research and Development 2014-06-30
NCT01138618 Hematological Clozapine Monitoring With a Point-of-care Device (CHEMPAQ) https://ClinicalTrials.gov/show/NCT01138618 Completed University of Aarhus 2010-12-31
NCT01092598 Factors Association With Poor Physical Function in Older Adults With Schizophrenia https://ClinicalTrials.gov/show/NCT01092598 Completed University of California, San Francisco 2012-06-30
NCT01088386 Zyprexa® Relprevv™ Patient Care Program https://ClinicalTrials.gov/show/NCT01088386 Enrolling by invitation Eli Lilly and Company 2021-05-31
NCT01053429 A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox Capsule https://ClinicalTrials.gov/show/NCT01053429 Completed Pfizer 2010-02-28
NCT01046526 fMRI Study of Nicotinic Effect on Neurophysiology of Schizophrenia https://ClinicalTrials.gov/show/NCT01046526 Completed National Institutes of Health Clinical Center (CC) NA
NCT01044914 Genes, Intermediate Phenotypes and Response to Quetiapine RX https://ClinicalTrials.gov/show/NCT01044914 Completed University of Bari 2010-10-31
NCT01043250 Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients https://ClinicalTrials.gov/show/NCT01043250 Completed Samsung Medical Center 2010-04-30
NCT01037075 Influence of Nicotine on Cognitive Function in Schizophrenic Patients With and Without Comorbid Drug Dependence https://ClinicalTrials.gov/show/NCT01037075 Completed National Institutes of Health Clinical Center (CC) NA
NCT01034085 Effects of Nicotine on Areas of Impaired and Preserved Functioning in Schizophrenia https://ClinicalTrials.gov/show/NCT01034085 Completed National Institutes of Health Clinical Center (CC) NA
NCT01036568 Neuroimaging Studies of Neurophysiological Phenotypes in Schizophrenia https://ClinicalTrials.gov/show/NCT01036568 Completed National Institutes of Health Clinical Center (CC) NA
NCT01031563 Risk Perception in Drug-Dependent Adults With and Without Schizophrenia https://ClinicalTrials.gov/show/NCT01031563 Completed National Institutes of Health Clinical Center (CC) NA
NCT01035996 Dopamine Function and Reward Processing In Schizophrenia https://ClinicalTrials.gov/show/NCT01035996 Completed National Institutes of Health Clinical Center (CC) NA
NCT01031433 Assessment of Craving in Nicotine-Dependent Patients With Schizophrenia Using Virtual Reality https://ClinicalTrials.gov/show/NCT01031433 Completed National Institutes of Health Clinical Center (CC) NA
NCT01028196 Observational Study to Evaluate Bipolar Disorder Symptoms in Patients Presented With Schizophrenia or Depression https://ClinicalTrials.gov/show/NCT01028196 Completed AstraZeneca 2010-11-30
NCT01026285 InORS - International Observational Registry on Schizophrenia With Injectable Risperidone and Oral Antipsychotics https://ClinicalTrials.gov/show/NCT01026285 Completed Janssen-Cilag International NV 2012-03-31
NCT01010620 Screening Protocol for Research Participants https://ClinicalTrials.gov/show/NCT01010620 Completed University of Maryland, Baltimore 2019-06-01
NCT01001481 Schizophrenia Treatment Adherence Investigation (STAI) https://ClinicalTrials.gov/show/NCT01001481 Completed Janssen-Cilag Pty Ltd 2009-09-30
NCT00999895 A Study Evaluating the Treatment Selection and Outcome When Changing Antipsychotic Treatment in Schizophrenic Patients https://ClinicalTrials.gov/show/NCT00999895 Completed AstraZeneca 2010-09-30
NCT00990626 Seroquel XR in Schizophrenia Relapse Prevention https://ClinicalTrials.gov/show/NCT00990626 Completed AstraZeneca 2010-07-31
NCT00984373 Epidemiology of Schizophrenia in Bulgaria https://ClinicalTrials.gov/show/NCT00984373 Completed AstraZeneca 2009-11-30
NCT00981123 Non-interventional (NI) Study to Observe Efficacy and Usage of Quetiapine in Acute Episodes of Schizophrenia and as Maintenance Therapy Following Standard Clinical Practice in Croatia https://ClinicalTrials.gov/show/NCT00981123 Completed AstraZeneca 2010-04-30
NCT00957294 Metabolic Syndrome in Patients With First-episode Schizophrenia https://ClinicalTrials.gov/show/NCT00957294 Completed University of Aarhus 2013-04-30
NCT00951418 Serum Clozapine and Cognition https://ClinicalTrials.gov/show/NCT00951418 Completed University of Aarhus 2010-03-31
NCT00952757 Changes in Hyperprolactinemia Secondary to Antipsychotics After Switching to Quetiapine https://ClinicalTrials.gov/show/NCT00952757 Completed Investigaciones Médicas Montejo S.L. 2008-08-31
NCT00937755 The Study of Atypical Antipsychotics-induced Metabolic Disturbances https://ClinicalTrials.gov/show/NCT00937755 Completed Taipei Medical University Hospital 2009-03-31
NCT00937716 Treatment Response in Schizophrenia: Bridging Imaging and Postmortem Studies https://ClinicalTrials.gov/show/NCT00937716 Active, not recruiting University of Alabama at Birmingham 2020-12-31
NCT00934726 Non-interventional Open Label Study to Investigate the Effect of Quetiapine XR on Patient Satisfaction and Quality of Life in Patients With Schizophrenia https://ClinicalTrials.gov/show/NCT00934726 Completed AstraZeneca 2010-10-31
NCT00921362 Seroquel (Quetiapine Fumarate) InPractice Evaluation Programme https://ClinicalTrials.gov/show/NCT00921362 Completed AstraZeneca NA
NCT00922090 A Non-interventional Study Evaluating the Clinical Benefit and Effectiveness of Quetiapine Fumarate Extended https://ClinicalTrials.gov/show/NCT00922090 Completed AstraZeneca 2010-01-31
NCT00877552 Prospective Studies of the Pathogenesis of Schizophrenia https://ClinicalTrials.gov/show/NCT00877552 Completed University of North Carolina, Chapel Hill 2019-12-31
NCT00873249 Effect of Daily Short Message System (SMS) Reminders on Medication Adherence to Oral Antipsychotics in Patients With Schizophrenia https://ClinicalTrials.gov/show/NCT00873249 Completed AstraZeneca 2010-03-31
NCT00857064 Subjective Well Being of Schizophrenic Patients in Greece https://ClinicalTrials.gov/show/NCT00857064 Completed AstraZeneca 2009-10-31
NCT00824031 Study of Mental Care in Spain https://ClinicalTrials.gov/show/NCT00824031 Completed AstraZeneca NA
NCT01534936 Atypical Antipsychotics in the Treatment of Affective Symptoms of Schizophrenia in Hungary https://ClinicalTrials.gov/show/NCT01534936 Completed AstraZeneca 2012-12-31
NCT00838123 Cognitive Functioning Related to Job Tenure Among Patients With Schizophrenia https://ClinicalTrials.gov/show/NCT00838123 Completed Far Eastern Memorial Hospital NA
NCT00814996 Social Functioning in Schizophrenia https://ClinicalTrials.gov/show/NCT00814996 Completed Far Eastern Memorial Hospital 2008-08-31
NCT00809731 Observational Study to Evaluate Efficacy and Remission Status for Schizophrenia Patients Under Atypical Treatment https://ClinicalTrials.gov/show/NCT00809731 Completed AstraZeneca 2010-09-30
NCT01698216 Switching From Consta® to Sustenna® in Patients With Schizophrenia https://ClinicalTrials.gov/show/NCT01698216 Completed Seoul National University Hospital 2015-05-31
NCT03076346 Neural Biomarkers of Clozapine Response https://ClinicalTrials.gov/show/NCT03076346 Recruiting University of Pittsburgh 2020-06-30
NCT02882204 Tracking Outcomes in Psychosis https://ClinicalTrials.gov/show/NCT02882204 Recruiting Lawson Health Research Institute 2022-12-31
NCT00782899 Four Dimensions in Schizophrenia https://ClinicalTrials.gov/show/NCT00782899 Completed AstraZeneca 2009-09-30
NCT00774085 An Observational Study to Assess Treatment & Outcomes Data in Patients Receiving Long-Acting Injectable Risperidone https://ClinicalTrials.gov/show/NCT00774085 Completed Janssen Cilag N.V./S.A. 2007-12-31
NCT00758251 Observation of Change in Clinical Global Impression Scores in Schizophrenia Patients Receiving Seroquel XR Treatment https://ClinicalTrials.gov/show/NCT00758251 Completed AstraZeneca 2009-03-31
NCT00750087 Non-interventional Study -Observe Treatment Efficacy in Maintaining Symptoms Control in Schizophrenia With Seroquel XR https://ClinicalTrials.gov/show/NCT00750087 Completed AstraZeneca 2009-09-30
NCT00749970 Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia https://ClinicalTrials.gov/show/NCT00749970 Completed AstraZeneca 2009-01-31
NCT00696813 Observational Study to Assess Outcomes During Antipsychotic Treatment With Paliperidone ER or Other Oral Antipsychotics https://ClinicalTrials.gov/show/NCT00696813 Completed Janssen-Cilag International NV 2011-01-31
NCT00690365 Safety and Efficacy of Switching to Quetiapine in Outpatients With Schizophrenia https://ClinicalTrials.gov/show/NCT00690365 Completed AstraZeneca 2008-04-30
NCT00692133 Spanish Validation of Tool Questionnaire to Assess Patients´Perception About Antipsychotic Treatment https://ClinicalTrials.gov/show/NCT00692133 Completed AstraZeneca 2008-08-31
NCT00689325 Evaluating Subjective Well-being in Schizophrenic Patients Treated With quetiapineXR® and Other Atypical Antipsychotics https://ClinicalTrials.gov/show/NCT00689325 Completed AstraZeneca 2010-01-31
NCT00686101 Knowledge and Perception of Smoking Risks/Consequences https://ClinicalTrials.gov/show/NCT00686101 Completed University of Maryland, Baltimore 2009-06-30
NCT00683891 FazaClo Outcomes in the Control of Schizophrenia (FOCUS) Study Survey https://ClinicalTrials.gov/show/NCT00683891 Completed Azur Pharma, Inc NA
NCT00697658 INVISION - An Observational Study to Explore Effectiveness, Tolerability and Safety of Paliperidone ER in Patients With Schizophrenia https://ClinicalTrials.gov/show/NCT00697658 Completed Janssen-Cilag B.V. 2009-11-30
NCT00666432 Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes https://ClinicalTrials.gov/show/NCT00666432 Active, not recruiting University of Maryland, Baltimore 2012-09-30
NCT00666146 Familial Schizophrenia and Spectrum Personality Disorders https://ClinicalTrials.gov/show/NCT00666146 Active, not recruiting University of Maryland, Baltimore 2010-07-31
NCT00644852 Medical Chart Review of Patients on Long-term Treatment With Long-acting Injectable Risperidone https://ClinicalTrials.gov/show/NCT00644852 Completed Johnson & Johnson Taiwan Ltd 2007-09-30
NCT00597168 Quality of Life in Schizophrenic Patients https://ClinicalTrials.gov/show/NCT00597168 Completed AstraZeneca 2009-10-31
NCT01259232 The Imaging Genetic Study of Schizophrenia and Family https://ClinicalTrials.gov/show/NCT01259232 Recruiting Kunming Medical University 2022-12-31
NCT00584519 Control of Metabolic and Cardiovascular Risk in Patients With Schizophrenia and Overweight https://ClinicalTrials.gov/show/NCT00584519 Completed Pfizer 2009-06-30
NCT00585273 Antipsychotics and Blood Vessel Function https://ClinicalTrials.gov/show/NCT00585273 Completed University of Iowa 2014-11-30
NCT00581932 Relationship Between Neurotransmitter Receptor Polymorphisms, Plasma Concentrations and Clinical Response to Clozapine https://ClinicalTrials.gov/show/NCT00581932 Completed University of Iowa 2015-12-31
NCT00579670 Treatment of Schizophrenic Patients With Ziprasidone https://ClinicalTrials.gov/show/NCT00579670 Completed Pfizer 2009-04-30
NCT00573300 Disturbances of Kynurenine Pathway of Trytophan Metabolism in Schizophrenia: A Quantitative Reverse Transcription Polymerase Chain Reaction (RT-PCR) Study https://ClinicalTrials.gov/show/NCT00573300 Completed North Suffolk Mental Health Association 2009-05-31
NCT00562926 Single Nucleotide Polymorphism (SNP) in Schizophrenia and Schizophrenia Spectrum Disorders: a Population Association Analysis With Hong Kong Chinese https://ClinicalTrials.gov/show/NCT00562926 Completed Hospital Authority, Hong Kong NA
NCT00560677 Schizophrenia and PTSD Project: Health, Interventions, and Risk/Resilience Evaluation(SAPPHIRE Study) https://ClinicalTrials.gov/show/NCT00560677 Active, not recruiting Durham VA Medical Center 2021-12-31
NCT00543088 Effectiveness of Anti-Psychotic in GPs Setting https://ClinicalTrials.gov/show/NCT00543088 Completed AstraZeneca NA
NCT00540267 Bone Density in Patients With Schizophrenia https://ClinicalTrials.gov/show/NCT00540267 Completed Inje University 2008-11-30
NCT00538122 Changes in Heart Rhythms Associated With Antipsychotic Drug Treatment https://ClinicalTrials.gov/show/NCT00538122 Completed Vanderbilt University 2008-07-31
NCT00538629 Noninterventional Study in Bipolar Disorder and Schizophrenia With Zeldox https://ClinicalTrials.gov/show/NCT00538629 Completed Pfizer 2008-04-30
NCT00536783 Schizophrenia Sensory Gating Deficit With Quetiapine https://ClinicalTrials.gov/show/NCT00536783 Completed New Mexico VA Healthcare System NA
NCT00534222 Unraveling the Relation of Patient’s Profile and Therapeutical Effects of Atypicals, Including Quetiapine Effect https://ClinicalTrials.gov/show/NCT00534222 Completed AstraZeneca NA
NCT00533260 A Non-interventional Naturalistic Project to Investigate the Effect of the Use of SMS Text Service on Treatment Adherence in Patients Treated With Seroquel® (Quetiapine) https://ClinicalTrials.gov/show/NCT00533260 Completed AstraZeneca 2008-04-30
NCT00528359 β-Cell Function in Schizophrenic Subjects on Atypical Antipsychotic drugS https://ClinicalTrials.gov/show/NCT00528359 Completed Cliniques universitaires Saint-Luc- Université Catholique de Louvain NA
NCT00524979 Digital Voice Analysis in Patients With Schizophrenia https://ClinicalTrials.gov/show/NCT00524979 Completed BeerYaakov Mental Health Center NA
NCT00523783 Seroquel Long-Term NIS for Schizophrenia Patients https://ClinicalTrials.gov/show/NCT00523783 Completed AstraZeneca 2007-11-30
NCT00510211 An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients. https://ClinicalTrials.gov/show/NCT00510211 Completed Eli Lilly and Company NA
NCT00501163 Direct Measurements of Cardiometabolic Risk in Treated Schizophrenia Patients https://ClinicalTrials.gov/show/NCT00501163 Completed Washington University School of Medicine 2012-05-31
NCT00501007 Predictors of Treatment Outcome for Smokers With and Without Schizophrenia https://ClinicalTrials.gov/show/NCT00501007 Completed Rutgers, The State University of New Jersey 2012-12-31
NCT00458367 RiSPECT: Risperdal Safety Protocol Evaluation Consta Treatment, a Post Authorization Safety Survey to Obtain Information on the Safety and Efficacy of Risperidone When Used in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT00458367 Completed Janssen Pharmaceutica N.V., Belgium NA
NCT00448630 An Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical Antipsychotics https://ClinicalTrials.gov/show/NCT00448630 Completed Pfizer 2008-07-31
NCT00423033 Qualitative Analysis on the Experiences of Employment Among Schizophrenic Patients https://ClinicalTrials.gov/show/NCT00423033 Completed Far Eastern Memorial Hospital 2007-09-30
NCT00419016 Association Between Schizophrenia and Cancer https://ClinicalTrials.gov/show/NCT00419016 Completed Sheba Medical Center NA
NCT00399334 PROFILe3: Epidemiologic Survey in Patients With Schizophrenia or Schizoaffective Disorders https://ClinicalTrials.gov/show/NCT00399334 Completed Janssen-Cilag, S.A. NA
NCT00392743 A Study to Compare Two Different Brain Imaging Techniques in Healthy Volunteers and in Schizophrenic Patients https://ClinicalTrials.gov/show/NCT00392743 Completed GlaxoSmithKline 2007-05-31
NCT00382915 Measuring Smoking Behavior in People With Schizophrenia and Bipolar Disorder https://ClinicalTrials.gov/show/NCT00382915 Completed Rutgers, The State University of New Jersey 2010-09-30
NCT00376233 Niacin Flushing as Marker of Cannabis Effects on Arachidonic Acid Pathways in Schizophrenia https://ClinicalTrials.gov/show/NCT00376233 Completed University of Jena NA
NCT00377117 Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population Part II https://ClinicalTrials.gov/show/NCT00377117 Completed Lawson Health Research Institute NA
NCT00358852 Scale Validation Study for Prediction of Relapse and Short Term Rehospitalization in Patients With Schizophrenia https://ClinicalTrials.gov/show/NCT00358852 Completed Janssen-Cilag, S.A. 2008-09-30
NCT00350935 Attention and Visual Perception in Schizophrenia: A Functional Magnetic Resonance Imaging (fMRI) Study https://ClinicalTrials.gov/show/NCT00350935 Completed University Hospital, Strasbourg, France NA
NCT00350805 Measuring Time Windows in Patients With Schizophrenia and Healthy Controls https://ClinicalTrials.gov/show/NCT00350805 Completed University Hospital, Strasbourg, France 2012-04-30
NCT00328952 Changes in Auditory Verbal Hallucination During Atypical Antipsychotic Treatment of Patients With Schizophrenia https://ClinicalTrials.gov/show/NCT00328952 Completed Seoul National University Hospital 2008-08-31
NCT00319904 The Partners Genetics Collaborative Study of Schizophrenia https://ClinicalTrials.gov/show/NCT00319904 Completed Massachusetts General Hospital 2017-10-31
NCT00312598 Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine https://ClinicalTrials.gov/show/NCT00312598 Completed University of North Carolina, Chapel Hill 2010-04-30
NCT00294008 A Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR) https://ClinicalTrials.gov/show/NCT00294008 Completed Janssen Korea, Ltd., Korea 2009-06-30
NCT00291200 Enhancing the Prospective Prediction of Psychosis https://ClinicalTrials.gov/show/NCT00291200 Completed Yale University 2009-02-28
NCT00283517 A Registry of Treatment Adherence for Patients With Schizophrenia https://ClinicalTrials.gov/show/NCT00283517 Completed Janssen-Cilag, S.A. NA
NCT00269464 Chronic Schizophrenia With Obsessive-Compulsive Symptoms: Comorbidity or a Subtype? https://ClinicalTrials.gov/show/NCT00269464 Completed Sheba Medical Center NA
NCT00264069 ADH.E.R.E.: Therapeutic ADHerence and Treatment Strategies: A Mental Health Registry https://ClinicalTrials.gov/show/NCT00264069 Completed Janssen-Cilag, S.A. NA
NCT00253240 Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population https://ClinicalTrials.gov/show/NCT00253240 Completed Lawson Health Research Institute NA
NCT00247637 The Genetic Basis of Inherited Neurologic Deficits in People With Schizophrenia https://ClinicalTrials.gov/show/NCT00247637 Completed University of California, San Diego 2008-09-30
NCT00246194 Observational Study in Patients With Schizophrenia Treated With Long-Acting Risperidone Injection (RISPERDAL CONSTA) https://ClinicalTrials.gov/show/NCT00246194 Completed Janssen, LP 2007-11-30
NCT00224276 Prevalence of Diabetes Mellitus Among Patients Treated With Atypical and Conventional Antipsychotics https://ClinicalTrials.gov/show/NCT00224276 Completed Yale University NA
NCT00222807 Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus https://ClinicalTrials.gov/show/NCT00222807 Completed University of Pittsburgh 2016-03-31
NCT00223522 Do Self-Report and Physician Impressions of Adherence to Oral Antipsychotic Medication Agree With Objective Data? https://ClinicalTrials.gov/show/NCT00223522 Completed The University of Texas Health Science Center at San Antonio NA
NCT00216723 Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar Disorder https://ClinicalTrials.gov/show/NCT00216723 Completed Korea Otsuka Pharmaceutical Co., Ltd. NA
NCT00184418 The Immune System and Psychiatric Disorders https://ClinicalTrials.gov/show/NCT00184418 Completed Norwegian University of Science and Technology 2008-01-31
NCT00172731 Measurement of Activity Participation for Persons With Schizophrenia Living in the Community https://ClinicalTrials.gov/show/NCT00172731 Completed National Taiwan University Hospital NA
NCT00161057 Functional Brain Activation Patterns in Schizophrenia, Measured Before and After Treatment https://ClinicalTrials.gov/show/NCT00161057 Completed UMC Utrecht NA
NCT00155701 Mutation Screening and Translocation Detection of DISC1 Gene in Schizophrenia https://ClinicalTrials.gov/show/NCT00155701 Completed National Taiwan University Hospital NA
NCT00155688 A Genetic Linkage Study of Schizophrenia https://ClinicalTrials.gov/show/NCT00155688 Completed National Taiwan University Hospital NA
NCT00155649 A Positional Cloning Study on Schizophrenia https://ClinicalTrials.gov/show/NCT00155649 Completed National Taiwan University Hospital NA
NCT00155818 Mutation Screening and Translocation Detection of DISC1 Gene in Schizophrenia https://ClinicalTrials.gov/show/NCT00155818 Completed National Taiwan University Hospital NA
NCT00155519 A Psychopathological Study of Latent (Early) Schizophrenia: Clinical Pathology/Neuropsychological Dysfunctions https://ClinicalTrials.gov/show/NCT00155519 Completed National Taiwan University Hospital NA
NCT00155506 Molecular Genetic Study of Schizophrenia: Parent-Offspring Trios https://ClinicalTrials.gov/show/NCT00155506 Completed National Taiwan University Hospital NA
NCT00135772 Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2 https://ClinicalTrials.gov/show/NCT00135772 Completed National Institute on Drug Abuse (NIDA) 2004-07-31
NCT00108303 Genetic Research in Schizophrenia Using DNA Markers and Clinical Phenotypes https://ClinicalTrials.gov/show/NCT00108303 Completed VA Office of Research and Development 2008-12-31
NCT00833456 NIS to Observe Improvement in Global Assessment of Functioning in Patients With Schizophrenia https://ClinicalTrials.gov/show/NCT00833456 Completed AstraZeneca 2010-11-30
NCT00080548 Timing of Voluntary Movement in Patients With Schizophrenia https://ClinicalTrials.gov/show/NCT00080548 Completed National Institutes of Health Clinical Center (CC) NA
NCT00012961 Improving Health Services for Veterans With Schizophrenia https://ClinicalTrials.gov/show/NCT00012961 Completed VA Office of Research and Development NA
NCT00836251 Effects of Antipsychotic Medications on Energy Intake and Expenditure https://ClinicalTrials.gov/show/NCT00836251 Completed Washington University School of Medicine 2008-06-30
NCT00006418 Molecular Genetics of Schizophrenia https://ClinicalTrials.gov/show/NCT00006418 Completed NorthShore University HealthSystem NA
NCT00001771 I-123 Brain Studies of Serotonin Metabolism in Psychiatric Patients and Normal Volunteers https://ClinicalTrials.gov/show/NCT00001771 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001323 Neuropsychiatric Evaluation of Healthy Volunteers and Adults With Schizophrenia https://ClinicalTrials.gov/show/NCT00001323 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001544 Genetic Aspects of Neurologic and Psychiatric Disorders https://ClinicalTrials.gov/show/NCT00001544 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001320 Neuroimaging of Dopamine Metabolism in Normal and Psychiatric Patients https://ClinicalTrials.gov/show/NCT00001320 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001192 Neuropsychological Evaluation of Psychiatric and Neurological Patients https://ClinicalTrials.gov/show/NCT00001192 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001258 Studies of Frontal Lobe Brain Functioning in Schizophrenia https://ClinicalTrials.gov/show/NCT00001258 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001921 Electrophysiology and Blood Flow in Patients With Schizophrenia and Their Siblings https://ClinicalTrials.gov/show/NCT00001921 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001920 Eye Blink Response in Healthy Volunteers and Adults With Schizophrenia https://ClinicalTrials.gov/show/NCT00001920 Completed National Institutes of Health Clinical Center (CC) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03302364 A Research in Pharmacogenomics and Accurate Medication of Risperidone https://ClinicalTrials.gov/show/NCT03302364 Recruiting Peking University First Hospital 2020-06-30
NCT03007303 The Relevance Between the microRNA-30e in Plasma and the Prognosis of Schizophrenia Patients https://ClinicalTrials.gov/show/NCT03007303 Recruiting Dalian Seventh People’s Hospital 2020-03-31
NCT02200588 Longitudinal Long-term Study (10 Years) of the Sample of First Episode of Non-affective Psychosis: PAFIP https://ClinicalTrials.gov/show/NCT02200588 Enrolling by invitation Fundación Marques de Valdecilla 2017-12-31
NCT03970005 Evaluation of Step-Based Care for Individuals at Clinical High Risk for Psychosis https://ClinicalTrials.gov/show/NCT03970005 Enrolling by invitation Ohio State University 2024-04-30
NCT03451734 Individualized Optimal Therapy of Antipsychotics https://ClinicalTrials.gov/show/NCT03451734 Recruiting Central South University 2018-10-01
NCT01246765 National Pregnancy Registry for Atypical Antipsychotics https://ClinicalTrials.gov/show/NCT01246765 Recruiting Massachusetts General Hospital 2022-12-31